Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.9 Billion CNY | 19.41% |
| 2022 | 4.11 Billion CNY | -11.85% |
| 2021 | 4.66 Billion CNY | -33.43% |
| 2020 | 7 Billion CNY | 13.94% |
| 2019 | 6.14 Billion CNY | 33.79% |
| 2018 | 4.59 Billion CNY | 20.72% |
| 2017 | 3.8 Billion CNY | 25.91% |
| 2016 | 3.02 Billion CNY | 18.19% |
| 2015 | 2.55 Billion CNY | 44.37% |
| 2014 | 1.77 Billion CNY | 22.15% |
| 2013 | 1.45 Billion CNY | 11.6% |
| 2012 | 1.3 Billion CNY | 25.94% |
| 2011 | 1.03 Billion CNY | 22.15% |
| 2010 | 845.21 Million CNY | 9.52% |
| 2009 | 771.71 Million CNY | 71.61% |
| 2008 | 449.7 Million CNY | -11.41% |
| 2007 | 507.64 Million CNY | 75.2% |
| 2006 | 289.75 Million CNY | 28.26% |
| 2005 | 225.9 Million CNY | 26.78% |
| 2004 | 178.17 Million CNY | 27.14% |
| 2003 | 140.14 Million CNY | 26.72% |
| 2002 | 110.59 Million CNY | 21.23% |
| 2001 | 91.22 Million CNY | 24.37% |
| 2000 | 73.35 Million CNY | 17.25% |
| 1999 | 62.56 Million CNY | 27.74% |
| 1998 | 48.97 Million CNY | 50.61% |
| 1997 | 32.51 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.63 Billion CNY | 68.91% |
| 2024 Q3 | 1.36 Billion CNY | -32.57% |
| 2024 Q2 | 2.01 Billion CNY | 23.33% |
| 2023 Q1 | 1.34 Billion CNY | 192.19% |
| 2023 Q4 | 968.57 Million CNY | -29.36% |
| 2023 Q2 | 1.22 Billion CNY | -8.83% |
| 2023 Q3 | 1.37 Billion CNY | 11.86% |
| 2023 FY | 4.9 Billion CNY | 19.41% |
| 2022 Q2 | 1.03 Billion CNY | -24.37% |
| 2022 Q1 | 1.36 Billion CNY | 434.55% |
| 2022 Q4 | 460.12 Million CNY | -63.28% |
| 2022 FY | 4.11 Billion CNY | -11.85% |
| 2022 Q3 | 1.25 Billion CNY | 21.33% |
| 2021 Q3 | 1.84 Billion CNY | 29.4% |
| 2021 Q2 | 1.42 Billion CNY | -20.77% |
| 2021 FY | 4.66 Billion CNY | -33.43% |
| 2021 Q1 | 1.8 Billion CNY | -0.73% |
| 2021 Q4 | -408.23 Million CNY | -122.12% |
| 2020 FY | 7 Billion CNY | 13.94% |
| 2020 Q1 | 1.61 Billion CNY | -4.72% |
| 2020 Q2 | 1.63 Billion CNY | 1.66% |
| 2020 Q3 | 1.94 Billion CNY | 18.5% |
| 2020 Q4 | 1.81 Billion CNY | -6.61% |
| 2019 Q1 | 1.4 Billion CNY | 29.5% |
| 2019 FY | 6.14 Billion CNY | 33.79% |
| 2019 Q2 | 1.47 Billion CNY | 5.08% |
| 2019 Q3 | 1.57 Billion CNY | 7.12% |
| 2019 Q4 | 1.69 Billion CNY | 7.12% |
| 2018 Q2 | 1.14 Billion CNY | -1.81% |
| 2018 Q3 | 1.2 Billion CNY | 4.85% |
| 2018 FY | 4.59 Billion CNY | 20.72% |
| 2018 Q1 | 1.16 Billion CNY | 15.1% |
| 2018 Q4 | 1.08 Billion CNY | -9.77% |
| 2017 Q3 | 923.67 Million CNY | 0.16% |
| 2017 Q1 | 948.38 Million CNY | 28.29% |
| 2017 Q4 | 1.01 Billion CNY | 9.73% |
| 2017 Q2 | 922.24 Million CNY | -2.76% |
| 2017 FY | 3.8 Billion CNY | 25.91% |
| 2016 Q4 | 739.26 Million CNY | -0.6% |
| 2016 Q1 | 809.1 Million CNY | 22.16% |
| 2016 Q3 | 743.73 Million CNY | 1.57% |
| 2016 FY | 3.02 Billion CNY | 18.19% |
| 2016 Q2 | 732.22 Million CNY | -9.5% |
| 2015 Q1 | 664.37 Million CNY | 62.91% |
| 2015 Q4 | 662.35 Million CNY | 9.55% |
| 2015 Q3 | 604.59 Million CNY | -3.66% |
| 2015 Q2 | 627.54 Million CNY | -5.54% |
| 2015 FY | 2.55 Billion CNY | 44.37% |
| 2014 Q1 | 472.87 Million CNY | 52.07% |
| 2014 FY | 1.77 Billion CNY | 22.15% |
| 2014 Q4 | 407.82 Million CNY | -7.14% |
| 2014 Q3 | 439.16 Million CNY | -2.97% |
| 2014 Q2 | 452.58 Million CNY | -4.29% |
| 2013 Q3 | 348.2 Million CNY | -9.79% |
| 2013 Q2 | 385.99 Million CNY | -4.91% |
| 2013 FY | 1.45 Billion CNY | 11.6% |
| 2013 Q1 | 405.9 Million CNY | 42.95% |
| 2013 Q4 | 310.96 Million CNY | -10.7% |
| 2012 Q4 | 283.95 Million CNY | -6.55% |
| 2012 Q1 | 373.25 Million CNY | 92.2% |
| 2012 Q2 | 339.15 Million CNY | -9.14% |
| 2012 Q3 | 303.84 Million CNY | -10.41% |
| 2012 FY | 1.3 Billion CNY | 25.94% |
| 2011 Q3 | 252.08 Million CNY | -4.43% |
| 2011 Q4 | 194.2 Million CNY | -22.96% |
| 2011 Q2 | 263.76 Million CNY | -18.17% |
| 2011 FY | 1.03 Billion CNY | 22.15% |
| 2011 Q1 | 322.33 Million CNY | 111.42% |
| 2010 Q4 | 152.46 Million CNY | -30.88% |
| 2010 Q1 | 241.63 Million CNY | 15.56% |
| 2010 Q2 | 230.54 Million CNY | -4.59% |
| 2010 Q3 | 220.57 Million CNY | -4.32% |
| 2010 FY | 845.21 Million CNY | 9.52% |
| 2009 Q4 | 209.09 Million CNY | 70.94% |
| 2009 FY | 771.71 Million CNY | 71.61% |
| 2009 Q2 | 193.83 Million CNY | -21.35% |
| 2009 Q1 | 246.46 Million CNY | 225.87% |
| 2009 Q3 | 122.32 Million CNY | -36.89% |
| 2008 Q4 | 75.63 Million CNY | -34.74% |
| 2008 Q3 | 115.88 Million CNY | -25.81% |
| 2008 Q2 | 156.19 Million CNY | 53.16% |
| 2008 Q1 | 101.98 Million CNY | -39.5% |
| 2008 FY | 449.7 Million CNY | -11.41% |
| 2007 Q2 | 78.06 Million CNY | -28.72% |
| 2007 Q4 | 168.57 Million CNY | 11.3% |
| 2007 Q3 | 151.46 Million CNY | 94.03% |
| 2007 Q1 | 109.52 Million CNY | 43.59% |
| 2007 FY | 507.64 Million CNY | 75.2% |
| 2006 Q2 | 62.85 Million CNY | -19.07% |
| 2006 Q1 | 77.67 Million CNY | 55.23% |
| 2006 Q4 | 76.27 Million CNY | 4.57% |
| 2006 FY | 289.75 Million CNY | 28.26% |
| 2006 Q3 | 72.94 Million CNY | 16.05% |
| 2005 Q1 | 63.18 Million CNY | 12.83% |
| 2005 Q2 | 52.32 Million CNY | -17.18% |
| 2005 Q3 | 60.35 Million CNY | 15.33% |
| 2005 Q4 | 50.03 Million CNY | -17.09% |
| 2005 FY | 225.9 Million CNY | 26.78% |
| 2004 Q2 | 25.49 Million CNY | -45.72% |
| 2004 FY | 178.17 Million CNY | 27.14% |
| 2004 Q4 | 56 Million CNY | 12.65% |
| 2004 Q1 | 46.96 Million CNY | 11.86% |
| 2004 Q3 | 49.71 Million CNY | 94.97% |
| 2003 Q1 | 33.88 Million CNY | 40.41% |
| 2003 Q3 | 38.97 Million CNY | 54.09% |
| 2003 FY | 140.14 Million CNY | 26.72% |
| 2003 Q4 | 41.99 Million CNY | 7.74% |
| 2003 Q2 | 25.29 Million CNY | -25.34% |
| 2002 Q4 | 24.12 Million CNY | 11.34% |
| 2002 Q2 | 45.33 Million CNY | 132.98% |
| 2002 Q1 | 19.45 Million CNY | 0.0% |
| 2002 FY | 110.59 Million CNY | 21.23% |
| 2002 Q3 | 21.67 Million CNY | -52.19% |
| 2001 FY | 91.22 Million CNY | 24.37% |
| 2000 FY | 73.35 Million CNY | 17.25% |
| 1999 FY | 62.56 Million CNY | 27.74% |
| 1998 FY | 48.97 Million CNY | 50.61% |
| 1997 FY | 32.51 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | -44.678% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | -522.874% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -5827.031% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 1071.658% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 13168.881% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | -229.043% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | -4176.45% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | -259.678% |